diazepam has been researched along with bromocriptine in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (33.33) | 18.7374 |
| 1990's | 4 (22.22) | 18.2507 |
| 2000's | 5 (27.78) | 29.6817 |
| 2010's | 3 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Milroy, E | 1 |
| Kullander, S | 1 |
| Becker, H; Bittkau, S; Przuntek, H; Schröder, J; Sczesni, B; Truong, DD; von Baumgarten, F | 1 |
| Fanghanel, G; Fanghanel, L; Larraza, O; Velasco, F; Velasco, M; Villalobos, M | 1 |
| Lazarus, A | 1 |
| Flechter, S; Graff, E; Oberman, Z; Rabey, JM; Vardi, J | 1 |
| Caraceni, TA; Giovannini, P; Girotti, F; Parati, EA; Pederzoli, M | 1 |
| Karson, CN | 1 |
| Grande Rodríguez, S; Real Rodríguez, B; Ruibal, JL; Sueiro Pita, B | 1 |
| Gan, Q; Knuepfer, MM | 1 |
| Kurasawa, M; Nakamura, K | 1 |
| Nishijima, K | 1 |
| Bildik, T; Ercan, ES; Erermis, S; Gockay, A; Karasoy, H; Tamar, M | 1 |
3 review(s) available for diazepam and bromocriptine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[The neuroleptic malignant syndrome in an adolescent. Its treatment with dantrolene, bromocryptin and diazepam].
Topics: Adolescent; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Antiparkinson Agents; Antipsychotic Agents; Bromocriptine; Dantrolene; Diazepam; Drug Therapy, Combination; Haloperidol; Humans; Imipramine; Lorazepam; Male; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Time Factors | 1996 |
[Neuroleptic malignant syndrome].
Topics: Antipsychotic Agents; Bromocriptine; Dantrolene; Diagnosis, Differential; Diazepam; Dopamine D2 Receptor Antagonists; Electroconvulsive Therapy; Fluid Therapy; Humans; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Receptors, Dopamine D2; Reference Standards; Secondary Prevention | 2003 |
1 trial(s) available for diazepam and bromocriptine
| Article | Year |
|---|---|
Effects of DA agonist in Huntington disease hyperkinesia.
Topics: Adult; Apomorphine; Bromocriptine; Clinical Trials as Topic; Cyproheptadine; Diazepam; Female; Growth Hormone; Humans; Huntington Disease; Lisuride; Male; Middle Aged | 1980 |
14 other study(ies) available for diazepam and bromocriptine
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Pharmacological management of common urodynamic problems.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Antidepressive Agents, Tricyclic; Bromocriptine; Diazepam; Enuresis; Female; Flavoxate; Humans; Male; Muscle, Smooth; Parasympatholytics; Urethra; Urinary Bladder; Urinary Bladder, Neurogenic; Urinary Incontinence; Urination Disorders | 1979 |
Effect of 2 br-alpha-ergocryptin (CB 154) on serum prolactin and the clinical picture in a case of progressive gigantomastia in pregnancy.
Topics: Adult; Breast Diseases; Bromocriptine; Carbamazepine; Diazepam; Epilepsy, Temporal Lobe; Ergolines; Female; Humans; Mephenytoin; Phenobarbital; Pregnancy; Pregnancy Complications; Prolactin | 1976 |
[Diagnostic and therapeutic aspects of neuroleptic malignant syndrome based on 12 cases].
Topics: Adult; Amantadine; Antipsychotic Agents; Bromocriptine; Dantrolene; Depressive Disorder; Diazepam; Drug Therapy, Combination; Female; Humans; Intellectual Disability; Lisuride; Male; Middle Aged; Neuroleptic Malignant Syndrome; Psychotic Disorders; Schizophrenia | 1991 |
Differential response to aminergic stimuli and biological behavior of growth hormone secreting pituitary adenomas.
Topics: Acromegaly; Adenoma; Adolescent; Adult; Bromocriptine; Cyproheptadine; Diazepam; Female; Growth Hormone; Humans; Male; Middle Aged; Pituitary Neoplasms; Thyrotropin-Releasing Hormone | 1990 |
Therapy of neuroleptic malignant syndrome.
Topics: Amantadine; Bromocriptine; Carbidopa; Combined Modality Therapy; Dantrolene; Diazepam; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electroconvulsive Therapy; Humans; Levodopa; Neuroleptic Malignant Syndrome; Receptors, Dopamine | 1986 |
Selective regional effect of various neuroactive drugs on bromocriptine concentration in the brain of rats.
Topics: Amantadine; Animals; Biperiden; Brain Chemistry; Bromocriptine; Carbidopa; Diazepam; Haloperidol; Levodopa; Methysergide; Naloxone; Rats | 1986 |
Spontaneous eye-blink rates and dopaminergic systems.
Topics: Animals; Apomorphine; Blinking; Bromocriptine; Diazepam; Dopamine; Dose-Response Relationship, Drug; Macaca mulatta; Sulpiride; Time Factors | 1983 |
Effects of proposed treatments for cocaine addiction on hemodynamic responsiveness to cocaine in conscious rats.
Topics: Animals; Bromocriptine; Buprenorphine; Cocaine; Desipramine; Diazepam; Dizocilpine Maleate; Hemodynamics; Male; Piperazines; Rats; Rats, Sprague-Dawley; Substance-Related Disorders | 1997 |
Anxiolytic effects of aniracetam in three different mouse models of anxiety and the underlying mechanism.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Bromocriptine; Diazepam; Disease Models, Animal; Dopamine Antagonists; Dose-Response Relationship, Drug; Fear; Fluvoxamine; Haloperidol; Indophenol; Male; Maze Learning; Mecamylamine; Mice; Mice, Inbred ICR; Moclobemide; Motor Activity; Nicotine; Nicotinic Antagonists; Nortriptyline; Physostigmine; Picolinic Acids; Pyrrolidinones; Serotonin Antagonists; Serotonin Receptor Agonists; Social Behavior; Stress, Psychological | 2001 |
Zuclopenthixol-induced neuroleptic malignant syndrome in an adolescent girl.
Topics: Adolescent; Anti-Anxiety Agents; Antidotes; Antipsychotic Agents; Bromocriptine; Clopenthixol; Delayed-Action Preparations; Diazepam; Dopamine Agonists; Female; Humans; Hypnotics and Sedatives; Injections, Intramuscular; Lithium Compounds; Lorazepam; Neuroleptic Malignant Syndrome; Treatment Outcome | 2007 |